Conspicuous by the their absence: Studies comparing and combining risperidone and applied behavior analysis to reduce challenging behavior in children with autism

Research in Autism Spectrum Disorders

Volumn 3, Issue 4, 2009, Pages 905-912

  Weeden, Marc ^a   Ehrhardt, Kristal ^a   Poling, Alan ^a  

^a WESTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

Applied behavior analysis; Autism; Challenging behavior; Risperidone

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; CLONIDINE; DEXAMPHETAMINE; GUANFACINE; METHYLPHENIDATE; PEMOLINE; PLACEBO; RISPERIDONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR DISORDER; BEHAVIOR THERAPY; BEHAVIORAL SCIENCE; CHECKLIST; CHILD; CHILD BEHAVIOR; CLINICAL TRIAL; COMMUNITY CARE; CONSULTATION; DEPRESSION; DEVELOPMENTAL DISORDER; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; HUMAN; INCREASED APPETITE; INTERMETHOD COMPARISON; IRRITABILITY; LETHARGY; PARENTAL BEHAVIOR; PRIORITY JOURNAL; REVIEW; SEDATION; SIDE EFFECT; SOCIAL INTERACTION; WEIGHT GAIN;

EID: 68749120563     PISSN: 17509467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rasd.2009.06.004     Document Type: Review

References (44)

1. Ahearn W.H., Clark K.M., MacDonald R.P.F., and Chung B.I. Assessing and treating vocal stereotypy in children with autism. Journal of Applied Behavior Analysis 40 (2007) 263-275
2. Aman M.G., DeSmeldt G., Derivan A., Lyons B., and Fielding R.L. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behavior disorders in children with subaverage intelligence. American Journal of Psychiatry 159 (2002) 1337-1346
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (2000), Author, Washington, DC
4. Athens E.S., Vollmer T.R., Sloman K.N., and Pipkin C.St.P. An analysis of vocal stereotypy and therapist fading. Journal of Applied Behavior Analysis 40 (2008) 291-297
5. Barkley R.A. Defiant children: A clinician's manual for parent training (1987), NY Guilford Press, New York
6. Barkley R.A. Commentary on the multimodal treatment study of children with ADHD. Journal of Abnormal Child Psychology 28 (2000) 595-599
7. Barlow D.H., and Hersen M. Single case experimental designs: Strategies for studying behavior change (1984), Allyn & Bacon, New York
8. Breggin P.R. A critical analysis of the NIMH Multimodal Treatment Study for Attention-Deficit/Hyperactivity Disorder (the MTA study). Ethical Human Sciences and Services 2 (2000) 63-72
9. Crosland K.A., Zarcone J.R., Lindauer S.E., Valdovinos M.G., Zarcone T.J., Hellings J.A., et al. Use of functional analysis methodology in the evaluation of medication effects. Journal of Autism and Developmental Disabilities 33 (2003) 271-279
10. Dermer M.L., and Hoch T.A. Improving description for single-subject experiments in research texts written for undergraduates. The Psychological Record 49 (1999) 49-66
11. Dwyer-Moore K.J., and Dixon M.R. Functional analysis and treatment of problem behavior of elderly adults in long-term care. Journal of Applied Behavior Analysis 40 (2007) 679-683
12. Fahmie T.A., and Hanley G.P. Progressing toward data intimacy: A review of within-session data analysis. Journal of Applied Behavior Analysis 41 (2008) 319-331
13. Forehand R., and MacMahon R. Helping the noncompliant child: A clinician's guide to parent training (1980), Guilford Press, New York, NY
14. Foxx R.M. Applied behavior analysis treatment of autism: The state of the art. Child and Adolescent Psychiatric Clinics of North America 17 (2008) 821-834
15. Garcia D., and Smith R.G. Using analog baselines to assess the effects of naltrexone on self-injurious behavior. Research in Developmental Disabilities 20 (1999) 1-21
16. Ghanizadeh A., and Kianpoor M. Cessation of risperidone-induced incontinency by valproate in a child with pervasive developmental disorder. Primary Psychiatry 15 (2008) 32-34
17. Green V.A., Pituch K.A., Itchon J., Choi A., O'Reilly M., and Sigafoos J. Internet survey of treatments used by parents of children with autism. Research in Developmental Disabilities 27 (2006) 70-84
18. Harwood T.M., and Beutler L.E. Commentary on Green and Ablon: What does the MTA study tell us about effective psychosocial treatment for ADHD?. Journal of Clinical Child and Adolescent Psychology 30 (2001) 141-143
19. Iwata B.A., Dorsey M.F., Slifer K.J., Bauman K.E., and Richman G.S. Toward a functional analysis of self-injury. Journal of Applied Behavior Analysis 27 (1994) 197-209 (Reprinted from Analysis and Intervention in Developmental Disabilities, 2, 3-20, 1982).
20. Jesner O.S., Aref-Adib M., and Coren E. Risperidone for autism spectrum disorder. Cochrane Database of Systematic Reviews 1 (2007) CD005040
21. Johnson J.M., and Pennypacker H.S. Strategies and tactics of behavioral research (2009), Psychology Press, London
22. Jones E.A., Feeley K.M., and Takacs J. Teaching spontaneous responses to young children with autism. Journal of Applied Behavior Analysis 40 (2007) 565-570
23. Kazdin A.E. Single-case research designs: Methods for clinical and applied settings (1982), Oxford University Press, New York
24. Kollins S., Ehrhardt K., and Poling A. Clinical drug assessment. In: Poling A., and Byrne T. (Eds). Introduction to behavioral pharmacology (2000), Context Press, Reno, NV 191-218
25. Langdon N.A., Carr E.G., and Owen-DeSchryver J.S. Functional analysis of precursors for serious problem behavior and related intervention. Behavior Modification 32 (2008) 804-827
26. Matson J.L., and Nebel-Schwam M. Assessing challenging behaviors in children with autism spectrum disorders: A review. Research in Developmental Disabilities 28 (2007) 567-579
27. McCracken J.T., McGough J., Shah B., Cronin P., Hong D., Aman M.G., et al. Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine 347 (2002) 314-321
28. Miral S., Gencer O., Inal-Emiroglu F.N., Baykara B., Baykara A., and Dirik E. Risperidone versus haloperidol in children and adolescents with AD: A randomized, controlled, double-blind trial. European Child and Adolescent Psychiatry 17 (2008) 1-8
29. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit hyperactivity disorder (ADHD). Archives of General Psychiatry 56 (1999) 1073-1086
30. MTA Cooperative Group. Mediators and moderators of treatment response for children with attention-deficit/hyperactivity disorder: The Multimodal Treatment Study of children with Attention Deficit Hyperactivity Disorder study. Archives of General Psychiatry 56 (1999) 1088-1096
31. Pelham W.E., and Hoza B. Comprehensive treatment for ADHD: Proposal for intensive summer treatment programs and outpatient follow-up. In: Hibbs E., and Jensen P. (Eds). Psychosocial treatment research of child and adolescent disorders (1996), American Psychiatric Press, Washington, DC 311-340
32. Poling A., and Ehrhardt K. Applied behavior analysis, social validation, and the psychopharmacology of mental retardation. Mental Retardation and Developmental Disabilities Research Reviews 5 (1999) 342-347
33. Poling A., Methot L., and LeSage M. Fundamentals of behavior analytic research (1995), Plenum Press, New York
34. Research Units on Pediatric Psychopharmacology (RUPP). Parent training for children with pervasive developmental disorders: A multi-site feasibility trial. Behavioral Interventions 22 (2007) 179-199
35. Scahill L., Aman M.G., McDougle C.J., Arnold L.E., McCracken J.T., Handen B., et al. Trial design challenges when combining medication and parent training in children with pervasive developmental disorders. Journal of Autism and Developmental Disorders 39 (2009) 720-1720
36. Scahill L., Koenig K., Carroll D.H., and Pachler M. Risperidone approved for the treatment of serious behavioral problems in children with autism. Journal of Child and Adolescent Psychiatric Nursing: Official Publication of the Association of Child and Adolescent Psychiatric Nurses, Inc 20 (2007) 188-190
37. Schroeder S.R. Issues and future directions of psychopharmacology in mental retardation. Psychopharmacology Bulletin 21 (1985) 323-326
38. Shea S., Turgay A., Carroll A., Schulz M., Orlik M., Smith I., et al. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 114 (2004) 634-641
39. Snyder R., Turgay A., Aman M.G., Binder C., Fisman S., and Carroll A. Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. Journal of the American Academy of Child and Adolescent Psychiatry 41 (2002) 1026-1046
40. Swanson J.M. School-based assessments and interventions for ADD students (1992), KC Publications, Irvine, CA
41. U.S. Food and Drug Administration. (2006). FDA approves the first drug to treat irritability associated with autism, Risperdal http://www.fda.gov/bbs/topics/NEWS/2006/NEW01485.html accessed May 28, 2009.
42. Valdovinos M.G., Ellringer N.P., and Alexander M.L. Changes in the rate of problem behavior associated with the discontinuation of the antipsychotic drug quetiapine. Mental Health Aspects of Developmental Disabilities 10 (2007) 64-67
43. Valdovinos M.G., Napolitano D.A., Zarcone J.R., Hellings J.A., Williams D.G., and Schroeder S.R. Multimodal evaluation of risperidone for destructive behavior: Functional analysis, direct observations, rating scales, and psychiatric impressions. Experimental and Clinical Psychopharmacology 10 (2002) 268-275
44. Zarcone J.R., Lindauer S.E., Morse P.S., Crosland K.A., Valdovinos M.G., McKerchar T.L., et al. Effects of risperidone on destructive behavior of persons with developmental disabilities: III Functional analysis. American Journal on Mental Retardation 109 (2004) 310-321